(Q46458606)

22 December 2017

title

The influence of ethnicity on warfarin dosage requirement (English)

1 reference

22 December 2017

1 reference

Mai-Trang N Dang

1

1 reference

22 December 2017

Julie Hambleton

series ordinal

2

1 reference

22 December 2017

Steven R Kayser

series ordinal

3

1 reference

22 December 2017

language of work or name

English

0 references

publication date

26 April 2005

1 reference

22 December 2017

Annals of Pharmacotherapy

published in

1 reference

22 December 2017

volume

39

1 reference

22 December 2017

page(s)

1008-1012

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

Aging and the anticoagulant response to warfarin therapy

cites work

1 reference

Effect of ageing upon warfarin dose requirements: a longitudinal study.

21 January 2018

1 reference

Factors affecting the maintenance dose of warfarin

21 January 2018

1 reference

Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long-term therapy

21 January 2018

1 reference

Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination.

21 January 2018

1 reference

Patient-specific factors predictive of warfarin dosage requirements

21 January 2018

1 reference

Long-term treatment with warfarin in Chinese population

21 January 2018

1 reference

Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0.

21 January 2018

1 reference

Factors determining the maintenance dose of warfarin in Chinese patients.

21 January 2018

1 reference

Interindividual variability in sensitivity to warfarin--Nature or nurture?

21 January 2018

1 reference

Differences in plasma binding of drugs between Caucasians and Chinese subjects.

21 January 2018

1 reference

Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.

21 January 2018

1 reference

Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes.

21 January 2018

1 reference

Implications of cytochrome P450 2C9 polymorphism on warfarin metabolism and dosing

21 January 2018

1 reference

Genetic polymorphism in exon 4 of cytochrome P450 CYP2C9 may be associated with warfarin sensitivity in Chinese patients

21 January 2018

1 reference

CYP2C9 exon 4 mutations and warfarin dose phenotype in Asians

21 January 2018

1 reference

Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E566

1 reference

22 December 2017

PubMed ID

15855242

1 reference

22 December 2017